Inspectors of the State Institute of Drugs and Good Practices participated in a mock GMP inspection
On October 8 and 9, inspectors of the State Institute of Drugs and Good Practices together with their peers from Armenia and Kazakhstan took part in a mock GMP inspection at the Gideon Richter Chemical Plant in Budapest, Hungary.
The inspection brought together representatives from three countries: the Department for Pharmaceutical Manufacture Inspections of the State Institute of Drugs and Good Practices (Russia), the Scientific Center for Drug and Medical Technology Expertise (Armenia), and the National Center for the Expertise of Medicinal Products, Devices and Equipment of the Kazakhstan Health Ministry.
The inspection pursued exchange of experience between the EAEU regulatory authorities during GMP inspections of pharmaceutical manufacturers. Additionally, such joint activities foster common principles of conducting inspections and help develop unified approaches towards classification of deviations.
«For the pharmaceutical community, joint mock GMP inspections are not only an opportunity to exchange practical knowledge, professional know-hows and to shape common standards and approaches towards inspection,» noted Vladislav Shestakov, director of the State Institute of Drugs and Good Practices. — It also means a new step on the path of the inter-regulatory dialogue regarding GMP inspection procedures between the EAEU member states.
- On 30 March 2021 FSI “SID & GP” and Ministry of the People’s Power for Health of the Bolivarian Republic of Venezuela signed a cooperation agreement
- Continuity of GxP – for the benefit of nations’ health
- Experts discussed the development potential of the pharmaceutical industry in the light of Pharma-2030 strategy
- “Solidarity training program”: uniting pharmaceutical industry and the world
- Russian delegation went to Uzbekistan with a business visit